Analyst consensus rating
Odyssey Therapeutics Analyst Rating: Strong Buy
Direct answer
Odyssey Therapeutics's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $34.67.
Forecast evidence checked November 16, 2026.
Get free Odyssey Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.14
- Average price target
- $34.67
- High price target
- $42.00
- Low price target
- $27.00
- Low target gap
- +41.1%
- Target upside
- +81.1%
- High target gap
- +119.4%
- Target range width
- 78.4%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- November 16, 2026
- Valid through
- November 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Odyssey Therapeutics?
Odyssey Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $34.67.
How far are Odyssey Therapeutics's low and high targets from the recorded price?
The low target implies +41.1%, while the high target implies +119.4%.
How many analysts are included in Odyssey Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is Odyssey Therapeutics's target upside or downside calculated?
The average target of $34.67 is divided by the recorded price of $19.14, then one is subtracted to produce +81.1%. This does not guarantee a future return.
When was Odyssey Therapeutics's analyst forecast verified?
The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.